$VLTS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Urigen Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Urigen Pharmaceuticals, Inc.. Get notifications about new insider transactions in Urigen Pharmaceuticals, Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 13 2009 | VLTS | Urigen Pharmaceuti ... | Parsons C. Lowell | Director | Buy | P | 0.07 | 10,000 | 700 | 1,978,693 | 2 M to 2 M (+0.51 %) |
| Oct 13 2009 | VLTS | Urigen Pharmaceuti ... | Parsons C. Lowell | Director | Buy | P | 0.07 | 10,000 | 650 | 1,968,693 | 2 M to 2 M (+0.51 %) |
| Oct 13 2009 | VLTS | Urigen Pharmaceuti ... | Parsons C. Lowell | Director | Buy | P | 0.07 | 13,000 | 845 | 1,958,693 | 1.9 M to 2 M (+0.67 %) |
| Oct 13 2009 | VLTS | Urigen Pharmaceuti ... | Parsons C. Lowell | Director | Buy | P | 0.06 | 20,000 | 1,200 | 1,945,693 | 1.9 M to 1.9 M (+1.04 %) |
| Sep 18 2009 | VLTS | Urigen Pharmaceuti ... | GOLDBERG MICHAEL M | Director | Option Exercise | J | 202,500.00 | 202,500 | 41,006,250,000 | 2,025,500 | |
| Aug 05 2009 | VLTS | Urigen Pharmaceuti ... | Parsons C. Lowell | Director | Buy | P | 0.07 | 20,000 | 1,400 | 1,925,693 | 1.9 M to 1.9 M (+1.05 %) |
| Jun 15 2009 | VLTS | Urigen Pharmaceuti ... | Shmagin Martin E | Chief Financial Of ... | Buy | P | 0.08 | 1,500 | 120 | 3,138,573 | 3.1 M to 3.1 M (+0.05 %) |
| Jun 05 2009 | VLTS | Urigen Pharmaceuti ... | Parsons C. Lowell | Director | Buy | P | 0.09 | 7,500 | 675 | 1,905,693 | 1.9 M to 1.9 M (+0.40 %) |
| May 29 2009 | VLTS | Urigen Pharmaceuti ... | Parsons C. Lowell | Director | Buy | P | 0.09 | 7,500 | 638 | 1,898,193 | 1.9 M to 1.9 M (+0.40 %) |
| May 29 2009 | VLTS | Urigen Pharmaceuti ... | Parsons C. Lowell | Director | Buy | P | 0.08 | 7,500 | 600 | 1,890,693 | 1.9 M to 1.9 M (+0.40 %) |
| Mar 18 2009 | VLTS | Urigen Pharmaceuti ... | Garner William J | Chief Executive Of ... | Buy | P | 0.09 | 1,000 | 90 | 18,587,340 | 18.6 M to 18.6 M (+0.01 %) |
| Mar 18 2009 | VLTS | Urigen Pharmaceuti ... | Shmagin Martin E | Chief Financial Of ... | Buy | P | 0.09 | 1,000 | 90 | 3,137,073 | 3.1 M to 3.1 M (+0.03 %) |
| Mar 18 2009 | VLTS | Urigen Pharmaceuti ... | Shmagin Martin E | Chief Financial Of ... | Buy | P | 0.09 | 1,000 | 90 | 3,136,073 | 3.1 M to 3.1 M (+0.03 %) |
| Mar 18 2009 | VLTS | Urigen Pharmaceuti ... | Shmagin Martin E | Chief Financial Of ... | Buy | P | 0.08 | 1,000 | 80 | 3,135,073 | 3.1 M to 3.1 M (+0.03 %) |
| Mar 26 2009 | VLTS | Urigen Pharmaceuti ... | Parsons C. Lowell | Director | Buy | P | 0.90 | 2,500 | 2,250 | 1,883,193 | 1.9 M to 1.9 M (+0.13 %) |
| Mar 17 2009 | VLTS | Urigen Pharmaceuti ... | Parsons C. Lowell | Director | Buy | P | 0.80 | 3,000 | 2,400 | 1,880,693 | 1.9 M to 1.9 M (+0.16 %) |
| Mar 17 2009 | VLTS | Urigen Pharmaceuti ... | Parsons C. Lowell | Director | Buy | P | 0.90 | 7,500 | 6,750 | 1,877,693 | 1.9 M to 1.9 M (+0.40 %) |
| Mar 16 2009 | VLTS | Urigen Pharmaceuti ... | Garner William J | Chief Executive Off ... | Buy | P | 0.09 | 1,000 | 90 | 18,586,340 | 18.6 M to 18.6 M (+0.01 %) |
| Mar 09 2009 | VLTS | Urigen Pharmaceuti ... | Parsons C. Lowell | Director | Buy | P | 0.08 | 6,000 | 480 | 1,870,193 | 1.9 M to 1.9 M (+0.32 %) |
| Mar 09 2009 | VLTS | Urigen Pharmaceuti ... | Parsons C. Lowell | Director | Buy | P | 0.10 | 1,500 | 150 | 1,864,193 | 1.9 M to 1.9 M (+0.08 %) |
| Mar 13 2009 | VLTS | Urigen Pharmaceuti ... | Shmagin Martin E | Chief Financial Of ... | Buy | P | 0.09 | 1,000 | 90 | 3,134,073 | 3.1 M to 3.1 M (+0.03 %) |
| Mar 13 2009 | VLTS | Urigen Pharmaceuti ... | Shmagin Martin E | Chief Financial Of ... | Buy | P | 0.09 | 2,000 | 180 | 3,133,073 | 3.1 M to 3.1 M (+0.06 %) |
| Mar 13 2009 | VLTS | Urigen Pharmaceuti ... | Shmagin Martin E | Chief Financial Of ... | Buy | P | 0.09 | 1,000 | 90 | 3,131,073 | 3.1 M to 3.1 M (+0.03 %) |
| Mar 13 2009 | VLTS | Urigen Pharmaceuti ... | Garner William J | Chief Executive Of ... | Buy | P | 0.09 | 1,000 | 90 | 18,585,340 | 18.6 M to 18.6 M (+0.01 %) |
| Mar 10 2009 | VLTS | Urigen Pharmaceuti ... | Shmagin Martin E | Chief Financial Off ... | Buy | P | 0.08 | 1,000 | 80 | 3,131,073 | 3.1 M to 3.1 M (+0.03 %) |
| Mar 10 2009 | VLTS | Urigen Pharmaceuti ... | Shmagin Martin E | Chief Financial Off ... | Buy | P | 0.08 | 4,000 | 320 | 3,130,073 | 3.1 M to 3.1 M (+0.13 %) |
| Mar 06 2009 | VLTS | Urigen Pharmaceuti ... | Garner William J | Chief Executive Off ... | Buy | P | 0.08 | 5,000 | 400 | 18,584,340 | 18.6 M to 18.6 M (+0.03 %) |
| Mar 02 2009 | VLTS | Urigen Pharmaceuti ... | Parsons C. Lowell | Director | Buy | P | 0.10 | 5,000 | 500 | 1,862,693 | 1.9 M to 1.9 M (+0.27 %) |
| Mar 02 2009 | VLTS | Urigen Pharmaceuti ... | Parsons C. Lowell | Director | Buy | P | 0.10 | 10,000 | 1,000 | 1,857,693 | 1.8 M to 1.9 M (+0.54 %) |
| Mar 02 2009 | VLTS | Urigen Pharmaceuti ... | Parsons C. Lowell | Director | Buy | P | 0.10 | 5,000 | 500 | 1,847,693 | 1.8 M to 1.8 M (+0.27 %) |
| Feb 26 2009 | VLTS | Urigen Pharmaceuti ... | Shmagin Martin E | Chief Financial Off ... | Buy | P | 0.12 | 1,000 | 120 | 3,126,073 | 3.1 M to 3.1 M (+0.03 %) |
| Feb 26 2009 | VLTS | Urigen Pharmaceuti ... | Shmagin Martin E | Chief Financial Off ... | Buy | P | 0.10 | 1,500 | 150 | 3,125,073 | 3.1 M to 3.1 M (+0.05 %) |
| Feb 26 2009 | VLTS | Urigen Pharmaceuti ... | Shmagin Martin E | Chief Financial Off ... | Buy | P | 0.12 | 1,000 | 120 | 3,123,573 | 3.1 M to 3.1 M (+0.03 %) |
| Feb 26 2009 | VLTS | Urigen Pharmaceuti ... | Garner William J | Chief Executive Of ... | Buy | P | 0.10 | 1,000 | 100 | 18,579,340 | 18.6 M to 18.6 M (+0.01 %) |
| Feb 03 2009 | VLTS | Urigen Pharmaceuti ... | Garner William J | Chief Executive Off ... | Buy | P | 0.13 | 10,000 | 1,300 | 18,578,340 | 18.6 M to 18.6 M (+0.05 %) |
| Feb 03 2009 | VLTS | Urigen Pharmaceuti ... | Garner William J | Chief Executive Off ... | Buy | P | 0.14 | 7,800 | 1,092 | 18,568,340 | 18.6 M to 18.6 M (+0.04 %) |
| Feb 03 2009 | VLTS | Urigen Pharmaceuti ... | Garner William J | Chief Executive Off ... | Buy | P | 0.15 | 16,000 | 2,400 | 18,560,540 | 18.5 M to 18.6 M (+0.09 %) |
| Feb 03 2009 | VLTS | Urigen Pharmaceuti ... | Shmagin Martin E | Chief Financial Off ... | Buy | P | 0.10 | 3,000 | 300 | 3,122,573 | 3.1 M to 3.1 M (+0.10 %) |
| Feb 03 2009 | VLTS | Urigen Pharmaceuti ... | Shmagin Martin E | Chief Financial Off ... | Buy | P | 0.13 | 1,000 | 130 | 3,119,573 | 3.1 M to 3.1 M (+0.03 %) |
| Jan 30 2009 | VLTS | Urigen Pharmaceuti ... | Shmagin Martin E | Chief Financial Off ... | Buy | P | 0.15 | 2,000 | 300 | 3,118,573 | 3.1 M to 3.1 M (+0.06 %) |
| Jan 30 2009 | VLTS | Urigen Pharmaceuti ... | Shmagin Martin E | Chief Financial Off ... | Buy | P | 0.14 | 1,000 | 140 | 3,117,573 | 3.1 M to 3.1 M (+0.03 %) |
| Jan 30 2009 | VLTS | Urigen Pharmaceuti ... | Shmagin Martin E | Chief Financial Off ... | Buy | P | 0.12 | 5,000 | 600 | 3,116,573 | 3.1 M to 3.1 M (+0.16 %) |
| Jan 30 2009 | VLTS | Urigen Pharmaceuti ... | Shmagin Martin E | Chief Financial Off ... | Buy | P | 0.11 | 2,500 | 275 | 3,111,573 | 3.1 M to 3.1 M (+0.08 %) |
| Jan 30 2009 | VLTS | Urigen Pharmaceuti ... | Shmagin Martin E | Chief Financial Off ... | Buy | P | 0.10 | 10,000 | 1,000 | 3,109,073 | 3.1 M to 3.1 M (+0.32 %) |
| Jan 30 2009 | VLTS | Urigen Pharmaceuti ... | Shmagin Martin E | Chief Financial Off ... | Buy | P | 0.09 | 5,000 | 450 | 3,099,073 | 3.1 M to 3.1 M (+0.16 %) |
| Jan 26 2009 | VLTS | Urigen Pharmaceuti ... | Shmagin Martin E | Chief Financial Off ... | Sell | P | 0.16 | 20,000 | 3,200 | 3,094,073 | 3.1 M to 3.1 M (-0.64 %) |
| Jan 26 2009 | VLTS | Urigen Pharmaceuti ... | Shmagin Martin E | Chief Financial Off ... | Sell | P | 0.14 | 20,000 | 2,700 | 3,074,073 | 3.1 M to 3.1 M (-0.65 %) |
| Jan 29 2009 | VLTS | Urigen Pharmaceuti ... | Garner William J | Chief Executive Off ... | Buy | P | 0.14 | 5,000 | 700 | 18,544,540 | 18.5 M to 18.5 M (+0.03 %) |
| Jan 29 2009 | VLTS | Urigen Pharmaceuti ... | Garner William J | Chief Executive Off ... | Buy | P | 0.10 | 5,000 | 500 | 18,539,540 | 18.5 M to 18.5 M (+0.03 %) |
| Jan 29 2009 | VLTS | Urigen Pharmaceuti ... | Garner William J | Chief Executive Off ... | Buy | P | 0.17 | 5,000 | 850 | 18,534,540 | 18.5 M to 18.5 M (+0.03 %) |
| Jan 22 2009 | VLTS | Urigen Pharmaceuti ... | Garner William J | Chief Executive Of ... | Buy | P | 0.05 | 48,000 | 2,160 | 18,529,540 | 18.5 M to 18.5 M (+0.26 %) |
| Jan 21 2009 | VLTS | Urigen Pharmaceuti ... | Garner William J | Chief Executive Off ... | Buy | P | 0.05 | 5,000 | 225 | 18,481,540 | 18.5 M to 18.5 M (+0.03 %) |
| Jan 21 2009 | VLTS | Urigen Pharmaceuti ... | Shmagin Martin E | Chief Financial Off ... | Buy | P | 0.11 | 25,000 | 2,750 | 3,054,073 | 3 M to 3.1 M (+0.83 %) |
| Jan 21 2009 | VLTS | Urigen Pharmaceuti ... | Shmagin Martin E | Chief Financial Off ... | Buy | P | 0.08 | 15,000 | 1,200 | 3,029,073 | 3 M to 3 M (+0.50 %) |
| Jan 21 2009 | VLTS | Urigen Pharmaceuti ... | Shmagin Martin E | Chief Financial Off ... | Buy | P | 0.07 | 50,000 | 3,500 | 3,014,073 | 3 M to 3 M (+1.69 %) |
| Jan 21 2009 | VLTS | Urigen Pharmaceuti ... | Shmagin Martin E | Chief Financial Off ... | Buy | P | 0.45 | 50,000 | 22,500 | 2,964,073 | 2.9 M to 3 M (+1.72 %) |
| Jul 02 2007 | VLTS | Urigen Pharmaceuti ... | MCGRAW BENJAMIN F III | COB, President and ... | Payment of Exercise | F | 0.16 | 1,771 | 283 | 42,215 | 44 K to 42.2 K (-4.03 %) |
| Apr 30 2007 | VLTS | Urigen Pharmaceuti ... | MCGRAW BENJAMIN F III | COB, President and ... | Payment of Exercise | F | 0.26 | 2,657 | 691 | 43,986 | 46.6 K to 44 K (-5.70 %) |
| Jan 31 2007 | VLTS | Urigen Pharmaceuti ... | MCGRAW BENJAMIN F III | COB, President and ... | Payment of Exercise | F | 0.26 | 3,162 | 822 | 46,643 | 49.8 K to 46.6 K (-6.35 %) |
| Nov 01 2006 | VLTS | Urigen Pharmaceuti ... | MARKEY JOSEPH A | VP of Finance & Adm ... | Payment of Exercise | F | 0.61 | 2,922 | 1,782 | 22,461 | 25.4 K to 22.5 K (-11.51 %) |
| Nov 01 2006 | VLTS | Urigen Pharmaceuti ... | REDDINGTON JOHN J | Chief Operating Off ... | Payment of Exercise | F | 0.61 | 4,834 | 2,949 | 29,462 | 34.3 K to 29.5 K (-14.09 %) |
| Nov 01 2006 | VLTS | Urigen Pharmaceuti ... | MCGRAW BENJAMIN F III | COB, President and ... | Payment of Exercise | F | 0.61 | 2,657 | 1,621 | 49,805 | 52.5 K to 49.8 K (-5.06 %) |
| Jul 31 2006 | VLTS | Urigen Pharmaceuti ... | REDDINGTON JOHN J | Chief Operating Off ... | Payment of Exercise | F | 0.40 | 1,318 | 527 | 34,296 | 35.6 K to 34.3 K (-3.70 %) |
| Jul 31 2006 | VLTS | Urigen Pharmaceuti ... | MCGRAW BENJAMIN F III | COB, President and ... | Payment of Exercise | F | 0.40 | 2,657 | 1,063 | 52,462 | 55.1 K to 52.5 K (-4.82 %) |
| Jul 31 2006 | VLTS | Urigen Pharmaceuti ... | MARKEY JOSEPH A | VP of Finance & Adm ... | Payment of Exercise | F | 0.40 | 797 | 319 | 25,383 | 26.2 K to 25.4 K (-3.04 %) |
| Jun 19 2006 | VLTS | Urigen Pharmaceuti ... | MCGRAW BENJAMIN F III | COB, President and ... | Option Exercise | A | 3.14 | 198,687 | 623,877 | 198,687 | |
| Jun 19 2006 | VLTS | Urigen Pharmaceuti ... | MCGRAW BENJAMIN F III | COB, President and ... | Option Exercise | A | 3.14 | 34,313 | 107,743 | 34,313 | |
| Jun 19 2006 | VLTS | Urigen Pharmaceuti ... | REDDINGTON JOHN J | Chief Operating Off ... | Option Exercise | A | 3.14 | 66,317 | 208,235 | 66,317 | |
| Jun 19 2006 | VLTS | Urigen Pharmaceuti ... | REDDINGTON JOHN J | Chief Operating Off ... | Option Exercise | A | 3.14 | 33,683 | 105,765 | 33,683 | |
| Jun 19 2006 | VLTS | Urigen Pharmaceuti ... | MARKEY JOSEPH A | VP of Finance & Adm ... | Option Exercise | A | 3.14 | 43,750 | 137,375 | 43,750 | |
| Jun 19 2006 | VLTS | Urigen Pharmaceuti ... | MARKEY JOSEPH A | VP of Finance & Adm ... | Option Exercise | A | 3.14 | 26,250 | 82,425 | 26,250 | |
| May 02 2006 | VLTS | Urigen Pharmaceuti ... | REDDINGTON JOHN J | Chief Operating Off ... | Payment of Exercise | F | 3.70 | 1,318 | 4,877 | 35,614 | 36.9 K to 35.6 K (-3.57 %) |
| May 02 2006 | VLTS | Urigen Pharmaceuti ... | MARKEY JOSEPH A | VP of Finance & Adm ... | Payment of Exercise | F | 3.70 | 947 | 3,504 | 26,180 | 27.1 K to 26.2 K (-3.49 %) |
| May 02 2006 | VLTS | Urigen Pharmaceuti ... | MCGRAW BENJAMIN F III | COB, President and ... | Payment of Exercise | F | 3.70 | 2,657 | 9,831 | 55,119 | 57.8 K to 55.1 K (-4.60 %) |
| Feb 01 2006 | VLTS | Urigen Pharmaceuti ... | MCGRAW BENJAMIN F III | COB, President and ... | Payment of Exercise | F | 3.16 | 3,177 | 10,039 | 57,776 | 61 K to 57.8 K (-5.21 %) |
| Feb 01 2006 | VLTS | Urigen Pharmaceuti ... | REDDINGTON JOHN J | Chief Operating Off ... | Payment of Exercise | F | 3.16 | 1,577 | 4,983 | 36,932 | 38.5 K to 36.9 K (-4.10 %) |
| Feb 01 2006 | VLTS | Urigen Pharmaceuti ... | MARKEY JOSEPH A | VP of Finance & Adm ... | Payment of Exercise | F | 3.16 | 953 | 3,011 | 27,127 | 28.1 K to 27.1 K (-3.39 %) |
| Jan 09 2006 | VLTS | Urigen Pharmaceuti ... | DIAZ REINALDO M | Director | Option Exercise | A | 2.20 | 10,000 | 22,000 | 46,000 | |
| Jan 13 2006 | VLTS | Urigen Pharmaceuti ... | REDDINGTON JOHN J | Chief Operating Off ... | Option Exercise | A | 2.22 | 75,000 | 166,500 | 75,000 | |
| Dec 05 2005 | VLTS | Urigen Pharmaceuti ... | LASEZKAY GEORGE M | Director | Option Exercise | A | 2.20 | 10,000 | 22,000 | 10,000 | |
| Dec 22 2005 | VLTS | Urigen Pharmaceuti ... | MENDELSON ALAN C | Director | Buy | P | 1.64 | 1,000 | 1,641 | 6,204 | 5.2 K to 6.2 K (+19.22 %) |
| Dec 06 2005 | VLTS | Urigen Pharmaceuti ... | MENDELSON ALAN C | Director | Option Exercise | A | 2.20 | 10,000 | 22,000 | 10,000 | |
| Dec 05 2005 | VLTS | Urigen Pharmaceuti ... | SCHROEDER JOHN S | Director | Option Exercise | A | 2.20 | 10,000 | 22,000 | 10,000 | |
| Dec 05 2005 | VLTS | Urigen Pharmaceuti ... | MCDADE MARK | Director | Option Exercise | A | 2.20 | 10,000 | 22,000 | 10,000 | |
| Dec 05 2005 | VLTS | Urigen Pharmaceuti ... | ENRIGHT PATRICK G | Director | Option Exercise | A | 2.20 | 10,000 | 22,000 | 10,000 | |
| Oct 31 2005 | VLTS | Urigen Pharmaceuti ... | MCGRAW BENJAMIN F III | COB, President and ... | Payment of Exercise | F | 2.40 | 2,657 | 6,377 | 60,953 | 63.6 K to 61 K (-4.18 %) |
| Oct 31 2005 | VLTS | Urigen Pharmaceuti ... | REDDINGTON JOHN J | Chief Operating Off ... | Payment of Exercise | F | 2.40 | 1,318 | 3,163 | 38,509 | 39.8 K to 38.5 K (-3.31 %) |
| Oct 31 2005 | VLTS | Urigen Pharmaceuti ... | REDDINGTON JOHN J | Chief Operating Off ... | Payment of Exercise | F | 2.40 | 1,318 | 3,163 | 38,509 | 39.8 K to 38.5 K (-3.31 %) |
| Oct 31 2005 | VLTS | Urigen Pharmaceuti ... | MARKEY JOSEPH A | VP of Finance & Adm ... | Payment of Exercise | F | 2.40 | 797 | 1,913 | 26,129 | 26.9 K to 26.1 K (-2.96 %) |
| Jul 12 2005 | VLTS | Urigen Pharmaceuti ... | MENDELSON ALAN C | Director | Buy | P | 2.64 | 600 | 1,584 | 5,000 | 4.4 K to 5 K (+13.64 %) |
| Jul 12 2005 | VLTS | Urigen Pharmaceuti ... | MENDELSON ALAN C | Director | Buy | P | 2.63 | 500 | 1,315 | 4,400 | 3.9 K to 4.4 K (+12.82 %) |
| Jul 12 2005 | VLTS | Urigen Pharmaceuti ... | MENDELSON ALAN C | Director | Buy | P | 2.64 | 500 | 1,320 | 3,900 | 3.4 K to 3.9 K (+14.71 %) |
| Jul 12 2005 | VLTS | Urigen Pharmaceuti ... | MENDELSON ALAN C | Director | Buy | P | 2.64 | 300 | 792 | 3,400 | 3.1 K to 3.4 K (+9.68 %) |
| Jul 12 2005 | VLTS | Urigen Pharmaceuti ... | MENDELSON ALAN C | Director | Buy | P | 2.66 | 1,300 | 3,458 | 3,100 | 1.8 K to 3.1 K (+72.22 %) |
| Jul 12 2005 | VLTS | Urigen Pharmaceuti ... | MENDELSON ALAN C | Director | Buy | P | 2.62 | 900 | 2,358 | 1,800 | 900 to 1.8 K (+100.00 %) |
| Jul 12 2005 | VLTS | Urigen Pharmaceuti ... | MENDELSON ALAN C | Director | Buy | P | 2.64 | 300 | 792 | 900 | 600 to 900 (+50.00 %) |
| Jul 12 2005 | VLTS | Urigen Pharmaceuti ... | MENDELSON ALAN C | Director | Buy | P | 2.64 | 300 | 792 | 600 | 300 to 600 (+100.00 %) |
| Jul 12 2005 | VLTS | Urigen Pharmaceuti ... | MENDELSON ALAN C | Director | Buy | P | 2.64 | 200 | 528 | 300 | 100 to 300 (+200.00 %) |
| Jul 12 2005 | VLTS | Urigen Pharmaceuti ... | MENDELSON ALAN C | Director | Buy | P | 2.64 | 100 | 264 | 100 | 0 to 100 |
| Jul 05 2005 | VLTS | Urigen Pharmaceuti ... | REDDINGTON JOHN J | Chief Operating Off ... | Option Exercise | A | 2.80 | 65,666 | 183,865 | 65,666 | |
| Jul 05 2005 | VLTS | Urigen Pharmaceuti ... | REDDINGTON JOHN J | Chief Operating Off ... | Option Exercise | A | 2.80 | 16,334 | 45,735 | 16,334 | |
| Jul 05 2005 | VLTS | Urigen Pharmaceuti ... | REDDINGTON JOHN J | Chief Operating Off ... | Grant | A | 0.00 | 29,507 | 0 | 39,827 | 10.3 K to 39.8 K (+285.92 %) |
| Jul 05 2005 | VLTS | Urigen Pharmaceuti ... | MARKEY JOSEPH A | VP of Finance & Adm ... | Option Exercise | A | 2.80 | 35,865 | 100,422 | 35,865 | |
| Jul 05 2005 | VLTS | Urigen Pharmaceuti ... | MARKEY JOSEPH A | VP of Finance & Adm ... | Option Exercise | A | 2.80 | 16,135 | 45,178 | 16,135 | |
| Jul 05 2005 | VLTS | Urigen Pharmaceuti ... | MARKEY JOSEPH A | VP of Finance & Adm ... | Grant | A | 0.00 | 17,839 | 0 | 26,926 | 9.1 K to 26.9 K (+196.31 %) |
| Jul 05 2005 | VLTS | Urigen Pharmaceuti ... | MCGRAW BENJAMIN F III | COB, President and ... | Option Exercise | A | 2.80 | 175,104 | 490,291 | 175,104 | |
| Jul 05 2005 | VLTS | Urigen Pharmaceuti ... | MCGRAW BENJAMIN F III | COB, President and ... | Option Exercise | A | 2.80 | 29,896 | 83,709 | 29,896 | |
| Jul 05 2005 | VLTS | Urigen Pharmaceuti ... | MCGRAW BENJAMIN F III | COB, President and ... | Grant | A | 0.00 | 59,464 | 0 | 63,610 | 4.1 K to 63.6 K (+1,434.25 %) |
| May 03 2005 | VLTS | Urigen Pharmaceuti ... | DIAZ REINALDO M | Director | Sell | S | 2.52 | 1 | 3 | 0 | 1 to 0 (-100.00 %) |
| May 03 2005 | VLTS | Urigen Pharmaceuti ... | DIAZ REINALDO M | Director | Sell | S | 2.48 | 34 | 84 | 1 | 35 to 1 (-97.14 %) |
| Mar 10 2005 | VLTS | Urigen Pharmaceuti ... | DIAZ REINALDO M | Director | Option Exercise | A | 2.75 | 10,000 | 27,500 | 46,000 | |
| Mar 10 2005 | VLTS | Urigen Pharmaceuti ... | SOROS FUND MANAGEMENT LLC | 10% Owner | Option Exercise | J | 2.75 | 10,000 | 27,500 | 10,000 | |
| Mar 10 2005 | VLTS | Urigen Pharmaceuti ... | PEARL FRANK H | 10% Owner | Option Exercise | J | 2.75 | 10,000 | 27,500 | 10,000 | |
| Mar 10 2005 | VLTS | Urigen Pharmaceuti ... | Purcell Dennis J | Director | Option Exercise | A | 2.75 | 10,000 | 27,500 | 10,000 | |
| Mar 09 2005 | VLTS | Urigen Pharmaceuti ... | MCDADE MARK | Director | Option Exercise | A | 2.75 | 10,000 | 27,500 | 10,000 | |
| Mar 09 2005 | VLTS | Urigen Pharmaceuti ... | SCHROEDER JOHN S | Director | Option Exercise | A | 2.75 | 10,000 | 27,500 | 10,000 | |
| Mar 09 2005 | VLTS | Urigen Pharmaceuti ... | LASEZKAY GEORGE M | Director | Option Exercise | A | 2.75 | 10,000 | 27,500 | 10,000 | |
| Mar 09 2005 | VLTS | Urigen Pharmaceuti ... | ENRIGHT PATRICK G | Director | Option Exercise | A | 2.75 | 10,000 | 27,500 | 10,000 | |
| Mar 09 2005 | VLTS | Urigen Pharmaceuti ... | MENDELSON ALAN C | Director | Option Exercise | A | 2.75 | 10,000 | 27,500 | 10,000 | |
| Dec 17 2004 | VLTS | Urigen Pharmaceuti ... | DIAZ REINALDO M | Director | Sell | S | 2.17 | 4 | 9 | 35 | 39 to 35 (-10.26 %) |
| Dec 17 2004 | VLTS | Urigen Pharmaceuti ... | DIAZ REINALDO M | Director | Sell | S | 2.16 | 64 | 138 | 39 | 103 to 39 (-62.14 %) |
| Dec 17 2004 | VLTS | Urigen Pharmaceuti ... | DIAZ REINALDO M | Director | Sell | S | 2.15 | 85 | 183 | 102 | 187 to 102 (-45.45 %) |
| Dec 17 2004 | VLTS | Urigen Pharmaceuti ... | DIAZ REINALDO M | Director | Sell | S | 2.09 | 9 | 19 | 188 | 197 to 188 (-4.57 %) |
| Dec 17 2004 | VLTS | Urigen Pharmaceuti ... | DIAZ REINALDO M | Director | Sell | S | 2.20 | 81 | 178 | 196 | 277 to 196 (-29.24 %) |
| Dec 17 2004 | VLTS | Urigen Pharmaceuti ... | DIAZ REINALDO M | Director | Sell | S | 2.18 | 8 | 17 | 277 | 285 to 277 (-2.81 %) |
| Dec 17 2004 | VLTS | Urigen Pharmaceuti ... | DIAZ REINALDO M | Director | Sell | S | 2.15 | 469 | 1,008 | 286 | 755 to 286 (-62.12 %) |
| Dec 17 2004 | VLTS | Urigen Pharmaceuti ... | DIAZ REINALDO M | Director | Sell | S | 2.12 | 7 | 15 | 755 | 762 to 755 (-0.92 %) |
| Dec 17 2004 | VLTS | Urigen Pharmaceuti ... | DIAZ REINALDO M | Director | Sell | S | 2.11 | 47 | 99 | 761 | 808 to 761 (-5.82 %) |
| Dec 16 2004 | VLTS | Urigen Pharmaceuti ... | DIAZ REINALDO M | Director | Sell | S | 2.11 | 68 | 143 | 556 | 624 to 556 (-10.90 %) |
| Dec 10 2004 | VLTS | Urigen Pharmaceuti ... | DIAZ REINALDO M | Director | Sell | S | 2.13 | 14 | 30 | 647 | 661 to 647 (-2.12 %) |
| Dec 10 2004 | VLTS | Urigen Pharmaceuti ... | DIAZ REINALDO M | Director | Sell | S | 2.41 | 6 | 14 | 661 | 667 to 661 (-0.90 %) |
| Dec 10 2004 | VLTS | Urigen Pharmaceuti ... | DIAZ REINALDO M | Director | Sell | S | 2.40 | 90 | 216 | 667 | 757 to 667 (-11.89 %) |
| Dec 10 2004 | VLTS | Urigen Pharmaceuti ... | DIAZ REINALDO M | Director | Sell | S | 2.45 | 6 | 15 | 756 | 762 to 756 (-0.79 %) |
| Dec 10 2004 | VLTS | Urigen Pharmaceuti ... | DIAZ REINALDO M | Director | Sell | S | 2.44 | 20 | 49 | 762 | 782 to 762 (-2.56 %) |
| Dec 10 2004 | VLTS | Urigen Pharmaceuti ... | DIAZ REINALDO M | Director | Sell | S | 2.42 | 23 | 56 | 781 | 804 to 781 (-2.86 %) |
| Dec 10 2004 | VLTS | Urigen Pharmaceuti ... | DIAZ REINALDO M | Director | Sell | S | 2.38 | 24 | 57 | 804 | 828 to 804 (-2.90 %) |
| Dec 14 2004 | VLTS | Urigen Pharmaceuti ... | DIAZ REINALDO M | Director | Sell | S | 2.13 | 24 | 51 | 623 | 647 to 623 (-3.71 %) |
| Dec 07 2004 | VLTS | Urigen Pharmaceuti ... | DIAZ REINALDO M | Director | Option Exercise | A | 1.97 | 10,000 | 19,700 | 36,000 | |
| Dec 07 2004 | VLTS | Urigen Pharmaceuti ... | MENDELSON ALAN C | Director | Option Exercise | A | 1.97 | 10,000 | 19,700 | 37,166 | |
| Dec 07 2004 | VLTS | Urigen Pharmaceuti ... | PEARL FRANK H | 10% Owner | Option Exercise | J | 1.97 | 10,000 | 19,700 | 10,000 | |
| Dec 07 2004 | VLTS | Urigen Pharmaceuti ... | Purcell Dennis J | Director | Option Exercise | A | 1.97 | 10,000 | 19,700 | 10,000 | |
| Dec 07 2004 | VLTS | Urigen Pharmaceuti ... | SOROS FUND MANAGEMENT LLC | 10% Owner | Option Exercise | J | 1.97 | 10,000 | 19,700 | 10,000 | |
| Dec 06 2004 | VLTS | Urigen Pharmaceuti ... | SCHROEDER JOHN S | Director | Option Exercise | A | 1.97 | 10,000 | 19,700 | 10,000 | |
| Dec 06 2004 | VLTS | Urigen Pharmaceuti ... | LASEZKAY GEORGE M | Director | Option Exercise | A | 1.97 | 10,000 | 19,700 | 10,000 | |
| Dec 06 2004 | VLTS | Urigen Pharmaceuti ... | MCDADE MARK | Director | Option Exercise | A | 1.97 | 10,000 | 19,700 | 10,000 | |
| Dec 06 2004 | VLTS | Urigen Pharmaceuti ... | ENRIGHT PATRICK G | Director | Option Exercise | A | 1.97 | 10,000 | 19,700 | 10,000 | |
| Dec 03 2004 | VLTS | Urigen Pharmaceuti ... | DIAZ REINALDO M | Director | Sell | S | 1.99 | 48 | 96 | 813 | 861 to 813 (-5.57 %) |
| Nov 23 2004 | VLTS | Urigen Pharmaceuti ... | DIAZ REINALDO M | Director | Sell | S | 1.99 | 32 | 64 | 876 | 908 to 876 (-3.52 %) |
| Nov 23 2004 | VLTS | Urigen Pharmaceuti ... | DIAZ REINALDO M | Director | Sell | S | 2.00 | 15 | 30 | 908 | 923 to 908 (-1.63 %) |
| Nov 22 2004 | VLTS | Urigen Pharmaceuti ... | DIAZ REINALDO M | Director | Sell | S | 2.02 | 16 | 32 | 924 | 940 to 924 (-1.70 %) |